✦ LIBER ✦

Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation

✍ Scribed by P. West; M. Schmiedeskamp; H. Neeley; J. Oberholzer; E. Benedetti; B. Kaplan

Book ID: 110904168
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 109 KB
Volume: 10
Category: Article
ISSN: 1398-2273
DOI: 10.1111/j.1399-3062.2007.00249.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

SUCCESSFUL TREATMENT OF RESISTANT CYTOME

SUCCESSFUL TREATMENT OF RESISTANT CYTOMEGALOVIRUS DUE TO UL97 AND UL54 MUTATIONS WITH HIGH-DOSE VALGANCICLOVIR

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 217 KB

Development of a point mutation assay fo

Development of a point mutation assay for the detection of human cytomegalovirus UL97 mutations associated with ganciclovir resistance

✍ E. Frances Bowen; Margaret A. Johnson; Paul D. Griffiths; Vincent C. Emery 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 788 KB

Value of a ligase chain reaction assay f

Value of a ligase chain reaction assay for detection of ganciclovir resistance-related mutation 594 in UL97 gene of human cytomegalovirus

✍ C Bourgeois; N Sixt; J.B Bour; P Pothier 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 147 KB

Case Report: Persistent cytomegalovirus

Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes

✍ Kumi Oshima; Yoshinobu Kanda; Shinichi Kako; Yuki Asano-Mori1; Takuro Watanabe; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB

## Abstract Addition of in vivo alemtuzumab to the conditioning regimen enabled 2‐ or 3‐locus‐mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft‐versus‐host‐disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivati